<DOC>
	<DOC>NCT02991261</DOC>
	<brief_summary>The objective of the study is to determine the relative bioavailability, safety and tolerability of SPARC001 and Reference001 in healthy, adult, male and female subjects</brief_summary>
	<brief_title>Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>1. Adult, male and female volunteers, 18 to 55 years of age, inclusive, at first CheckIn Visit 2. Body mass index (BMI) ≥18 to ≤30 kg/m2 and total body weight &gt;50 kg (110 lbs) at Screening 3. All female subjects must have a negative serum pregnancy test at Screening and at each Checkin Visit 4. Medically healthy on the basis of medical history and physical examination (including but not limited to an evaluation of the cardiovascular, gastrointestinal, respiratory and central nervous systems), as determined by the Investigator at Screening and each CheckIn Visit. 1. Females who are pregnant, lactating, or likely to become pregnant during the study 2. Lifetime history and/or recent evidence of alcohol or drug/substance abuse disorder 3. Subjects who need to maintain mental alertness throughout the study 4. Subjects determined by the investigator to have any medical condition that could jeopardize their health or prejudice the results</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>